VIM-1 carbapenemase-producing Escherichia coli isolated from retail seafood,
Germany 2016 by Roschanski, Nicole et al.
1www.eurosurveillance.org
Research article
VIM-1 carbapenemase-producing Escherichia coli 
isolated from retail seafood, Germany 2016
Nicole Roschanski¹, Sebastian Guenther¹, Thi Thu Tra Vu², Jennie Fischer³, Torsten Semmler⁴, Stephan Huehn2,5, Thomas Alter², 
Uwe Roesler¹
1. Freie Universitaet Berlin, Institute for Animal Hygiene and Environmental Health, Berlin, Germany
2. Freie Universitaet Berlin, Institute of Food Safety and Food Hygiene, Berlin, Germany
3. Federal Institute for Risk Assessment, Department Biological Safety, Berlin, Germany
4. Robert Koch Institute, Berlin, Germany
5. Beuth University of Applied Sciences, Life Science and Technology, Berlin, Germany
Correspondence: Nicole Roschanski (nicole.roschanski@fu-berlin.de)
Citation style for this article: 
Roschanski Nicole, Guenther Sebastian, Vu Thi Thu Tra, Fischer Jennie, Semmler Torsten, Huehn Stephan, Alter Thomas, Roesler Uwe. VIM-1 carbapenemase-
producing Escherichia coli isolated from retail seafood, Germany 2016. Euro Surveill. 2017;22(43):pii=17-00032. https://doi.org/10.2807/1560-7917.
ES.2017.22.43.17-00032 
Article submitted on 10 Jan 2017 / accepted on 15 May 2017 / published on 26 Oct 2017
Carbapenems belong to the group of last resort anti-
biotics in human medicine. Therefore, the emergence 
of growing numbers of carbapenemase-producing 
bacteria in food-producing animals or the environ-
ment is worrying and an important concern for the 
public health sector. In the present study, a set of 
45 Enterobacteriaceae isolated from German retail 
seafood (clams and shrimps), sampled in 2016, were 
investigated by real-time PCR for the presence of 
carbapenemase-producing bacteria. One  Escherichia 
coli  (ST10), isolated from a Venus clam (Ruditapes 
philippinarum) harvested in the Mediterranean Sea 
(Italy), contained the carbapenemase gene  blaVIM-1  as 
part of the variable region of a class I integron. Whole-
genome sequencing indicated that the integron was 
embedded in a Tn3-like transposon that also contained 
the fluoroquinolone resistance gene qnrS1. Additional 
resistance genes such as the extended-spectrum beta-
lactamase  blaSHV-12  and the AmpC gene  blaACC-1  were 
also present in this isolate. Except  blaACC-1, all resist-
ance genes were located on an IncY plasmid. These 
results confirm previous observations that carbapene-
mase-producing bacteria have reached the food chain 
and are of increasing concern for public health.
Introduction 
In human medicine, carbapenems are one of the 
last treatment options for serious infections caused 
by multidrug-resistant Gram-negative bacteria [1]. 
Therefore, the increasing number of reports describ-
ing carbapenemase-producing Enterobacteriaceae are 
worrying. In the past six years, it has become obvious 
that the occurrence of carbapenemase-producing bac-
teria is no longer limited to clinical settings. Increasing 
numbers of carbapenemase-producing bacteria have 
been isolated from the environment, wild birds and 
companion and food-producing animals all over the 
world [2]. Although the use of carbapenems is prohib-
ited in food-producing animals and restricted for pets 
in most European countries, these findings illustrate 
the continuous spread of these highly resistant bacte-
ria accompanied by emerging public health problems. 
In 2011, the first VIM-1 producing  Salmonella  Infantis 
and Escherichia coli were isolated in German fattening 
farms for pigs and chickens [3,4].
European Union legislation implemented monitoring 
of carbapenem-resistance in  Salmonella  and  E. coli  in 
food-producing animals (chickens, turkeys, pigs and 
cattle) and the derived meat samples [5]. Similarly 
structured resistance surveillance programmes, tar-
geting bacterial isolates derived from food-produc-
ing animals and retail meat, are in place globally [6]. 
Vegetables, fruits or seafood are frequently consumed 
raw and thus may become a source of antimicrobial 
resistant bacteria, including carbapenemase-produc-
ing microorganisms [6-8]. Microbial contamination of 
the environment with faecal bacteria is an important 
route of transmission. For example, bacteria in river 
water may move on to seas and oceans [9]. Therefore, 
seafood harvested from contaminated regions serves 
as a vehicle for the transmission of these bacteria [10]. 
On the other hand, aquaculture is a fast-growing food 
production sector [11].
To prevent bacterial infections in the farmed fish, inten-
sive aquaculture is often accompanied by increased 
use of a wide range of chemotherapeutic agents, in 
particular antibiotics [11]. This situation supports the 
occurrence and spread of antibiotic-resistant bacteria 
in seafood products. Fish and seafood play an impor-
tant role on the food market. The global food fish sup-
ply has increased at an average annual rate of 3.2% 
(1961–2013); fish consumption per capita increased 
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similarly from an average of 9.9 kg/year in the 1960s 
to 20.1 kg/year in 2014 [12]. Several publications report 
the presence of antibiotic-resistant bacteria in seafood 
[10,13-15]. The first carbapenemase-producing bacteria 
derived from seafood were described in 2014, when 
a  blaVIM-2  containing  Pseudomonas fluorescens  was 
isolated from a squid from South Korea [8]. One year 
later, a study described the occurrence of blaOXA-48-pro-
ducing bacteria in 3.3% of the investigated seafood 
samples (squid, sea squirt, clams and seafood medley) 
from China and Korea [6].
In the present study, seafood samples from retail mar-
kets in Berlin, Germany, were investigated for the pres-
ence of carbapenemase-producing Enterobacteriaceae.
Methods
Detection of carbapenemase-producing 
Enterobacteriaceae
A set of 160 seafood samples (80 shrimp, 49 blue mus-
sels, 15 Venus clams, 11 razor shells and five cockles) 
derived from 12 independent sellers in Berlin was 
sampled between December 2015 and August 2016 
and initially investigated for the presence of ESBL/
AmpC-producing bacteria (data not shown). In that 
set, 45 Enterobacteriaceae were isolated:  Klebsiella 
pneumoniae  (n = 13) and  E. coli  (n = 12) were the 
predominant species, followed by  Enterobacter 
cloacae  (n = 6),  Citrobacter freundii  (n = 5),  Hafnia 
alvei  (n = 3), Pantoea septica  (n = 1), Enterobacter aero-
genes  (n = 1),  Morganella morganii  (n = 1),  Citrobacter 
braakii (n = 1), Enterobacter asburiae (n = 1) and Leclercia 
adecarboxylata (n = 1). In the present study, the 45 DNA 
samples were additionally screened for the presence 
of the carbapenemase encoding genes  blaVIM,  blaKPC, 
blaNDM,  blaOXA-48  and  blaGES  by real-time PCR [16]. The 
detected  blaVIM-1  gene was amplified and sequenced 
[17].
Further characterisation of a blaVIM-1-containing Escherichia coli isolate
The phylogenetic group was determined by PCR [18], 
the class I integron was amplified and the purified 
amplification products were sequenced as described 
previously [4]. Plasmid DNA was isolated using the 
NucleoBond Xtra Midi kit (Macherey-Nagel, Dueren, 
Germany) and the  blaVIM-1-containing plasmid was 
transferred into electrocompetent  E. coliNEB10-beta 
(New England Biolabs, Frankfurt a.M., Germany). The 
incompatibility (Inc-) group of the plasmid was deter-
mined by using the PCR-based replicon typing (PBRT) 
kit (Diatheva, Fano, Italy). The size of the  blaVIM-
1-containing plasmid was estimated by S1 nuclease 
pulsed-field gel electrophoresis (PFGE) [19] using the 
following running conditions: 1–25 s, 17 h, 6 V/cm, 120 
V. In addition, genomic DNA from the E. coli wild-type 
strain E-124–4 as well as the transformant TE-124–4  and 
the recipient strain NEB10-beta was isolated from 
overnight cultures of the selected isolates using the 
PureLink Genomic DNA Mini Kit (Invitrogen, Waltham, 
United States (US)). Sequencing libraries were gener-
ated with the Nextera XT DNA Sample Preparation Kit 
and paired-end sequencing was performed on the 
Illumina MiSeq benchtop using the MiSeq Reagent 
v3 600-cycle Kit (2 × 300 bp) (Illumina, San Diego, 
US). The raw data were assembled de novo using CLC 
Genomics workbench v.9.0 (http://www.clcbio.com/). 
Resistance genes, plasmid incompatibility groups as 
well as multilocus sequence types were identified using 
the Web-tools ResFinder 2.1 [20], PlasmidFinder 1.3 [21], 
VirulenceFinder 1.5 [22] and MLST 1.8 [23], using the 
scheme by Wirth et al. [24]. Plasmid sequences were 
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GenBank accession number of the blaVIM-1 containing transposon region of pE-124-4: MG182343.*
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extracted from the set of whole genome data by reduc-
tive sequence analysis of the transformant and the 
recipient strain. The resulting plasmid contigs where 
compared with available plasmid sequences using the 
Basic Local Alignment Search Tool (BLAST; National 
Center for Biotechnology Information;  https://blast.
ncbi.nlm.nih.gov/Blast.cgi?PAGE_TYPE=BlastSearch) 
and the software Geneious 7.1.2. Insertion sequence 
elements were detected by using the IS Finder (https://
www-is.biotoul.fr/blast.php).
Minimal inhibitory concentrations for a set of differ-
ent antibiotics were investigated using the VITEK-2 
compact system and the AST-card N248 (bioMérieux, 
Nuertingen, Germany). In addition, a disc diffusion 
assay described by the norm CLSI-M02-A11 [25] was 
performed using the following carbapenem discs: 
meropenem (MEM) (10 µg), imipenem (IMI) (10µg) and 
ertapenem (ETP) (10 µg) (bestbion, Cologne, Germany). 
The obtained data were interpreted following Clinical 




Among the 45 investigated Enterobacteriaceae, one E. 
coli  isolate (E-124–4) was found to be positive for the 
carbapenemase gene  blaVIM-1. The isolate belonged to 
the phylogenetic group A, sequence type ST10, and was 
originally isolated from a Venus clam (Ruditapes philip-
pinarum). Plasmid electroporation, replicon typing, 
S1 nuclease PFGE (data not shown) as well as whole 
genome sequence data (E-124–4: coverage 130×, con-
tigs n = 157; TE-124–4: coverage 100×, contigs n = 203; 
NEB10-beta coverage 120×, contigs: n = 142) indicated 
that the carbapenemase gene was located on an IncY 
plasmid (pE-124–4) of ca 194 kb. Sequence analyses 
showed that blaVIM-1 was located within a class I integron 
(E-124-4 GenBank accession number: PDDP00000000). 
Besides the carbapenemase gene  blaVIM-1, genes for 
the aminoglycoside 6’-N-acetyltransferase  aacA4, the 
aminoglycoside phosphotransferase  aph(3’)-XV, the 
aminoglycoside adenylyltransferase  aadA1 as well 
as the chloramphenicol acetyltransferase  catB2 were 
detected in the variable region of the integron (Figure).
In addition, the conserved region at the 3’- end con-
tained the sulphonamide resistance gene sul1. Besides 
the class I integron, the investigated isolate harboured 
eight additional antibiotic resistance genes conferring 
resistance to different classes of antimicrobials (Table 
1).
The S1-PFGE (data not shown) confirmed the pres-
ence of a single plasmid in TE-124–4. A genome compari-
son of the wildtype as well as the transformant and 
the recipient strain showed that 13 of the 14 detected 
resistance genes were co-located on the  blaVIM-1-con-
taining IncY plasmid. Only the AmpC gene  blaACC-1  was 
not transferred to the recipient strain. The whole 
genome data indicated that this gene was located on 
the E. coli  chromosome. At the 5’-end, the blaACC-1 was 
associated with the insertion sequence ISEcp1 followed 
by the genes  sgbE (2-ribulose-5-phosphate-4-epime-
rase),  rhaR (transcriptional activator) and  yicJ2 (inner 
membrane symporter) and on the 3’-end, ISKpn7  was 
detected adjacent to the genes gdhA (glutamate dehy-
drogenase), ulaE (L-ribulose-5-phosphate-3-epimerase) 
and sgbH (3-keto-L-gluconate-6-phosphate-decar-
boxylase). Comparison of the extracted IncY plas-
mid sequences showed that the plasmid contained 
a mixture of different plasmid components and had 
low overall similarity with all published IncY plas-
mids carrying  blaVIM-1. It is noteworthy that the class I 
integron detected here was located within a Tn3-like 
transposon, similar to the one previously reported in 
a  K. pneumoniae  isolated from a river in Switzerland 
[27]. The region located proximal to the class I integron 
contained the  qnrS1 gene,  tniR encoding a resolvase/
integrase, the Tn3-like transposase, ISKrA4  as well as 
the putative transposon resolvase  ydaA. However, at 
the distal end of the integron, only the Tn3-like trans-
posase was located adjacent to the sul1 gene (Figure).
Table 1
Whole genome sequence comparison of the Escherichia coli wild-type isolate (E-124–4) derived from retail seafood and its 
transformant (TE-124–4), Germany, 2016
Isolate ST Resistance genes Plasmid incompatibility group
Genes associated 
with virulence
E-124–4 ST-10 aacA4-like, aadA1, aph(3‘)-XV, blaACC-1, blaSHV-12, blaVIM-1, catB2, dfrA14-like, mph(A), qnrS1, strA-like, strB-like, sul1, sul2 IncY gad
TE-124–4 ST-1060
aacA4-like, aadA1, aph(3‘)-XV, blaSHV-12, blaVIM-1, catB2, dfrA14-
like, mph(A), qnrS1, strA-like, strB-like, sul1, sul2 IncY gad, iss
NEB10-
beta ST-1060 none none gad, iss
ST: sequence type.
E-124-4 GenBank accession number: PDDP00000000.




Besides the genetic background, we also investigated 
phenotypic resistances at two different time points: 
first, the minimal inhibitory concentration (MIC) for 
the wildtype isolate E-124–4 was determined imme-
diately after the PCR-detection of the  blaVIM-1  gene (11 
August 2016). At this time point, no carbapenem resist-
ance against IMI as well as MEM was detected using 
the VITEK-2 compact system (Table 2). Due to the fact 
that ETP was not included on the AST card N248 and 
the presence of the  blaVIM-1  gene was already proved 
by sequencing, the results were reassessed by disc 
diffusion including the three carbapenems IMI, MEM 
and ETP. Thereby the following zone diameters were 
obtained: IMI: 21 mm; MEM: 24 mm; ETP: 25 mm. 
According to CLSI-M100-S24, these diameters indi-
cated a carbapenem-sensitive phenotype. However, 
according to the European Food Safety Authority, 
the measured zone diameters of 24 mm for MEM and 
25 mm for ETP were indicative of non-susceptibility to 
carbapenems [28]. A simultaneous cultivation in liquid 
medium containing either 2 µg/mL or 8 µg/mL merope-
nem indicated that the isolate was able to grow under 
selective conditions.
Following the completion of the other experiments 
such as plasmid preparation and transformation, the 
MIC determination was repeated on 21 September 2016 
and showed that E-124–4 as well as its transformant 
TE-124–4 had gained full carbapenem resistance (Table 2).
Discussion
Increasing numbers of antibiotic-resistant 
Enterobacteriaceae cause continuous problems in 
infection control and the global spread of carbapen-
emase-producing bacteria is especially worrisome 
[29]. In this study, we describe a  blaVIM-1-contain-
ing  E. coli  (ST10) isolate derived from a Venus clam, 
harvested in the Mediterranean Sea (Italy) and 
purchased at a German retail market. This emphasises 
the importance of the food production chain in the 
global spread of antibiotic-resistant bacteria.
At the same time, it has to be considered that the detec-
tion of carbapenemase producers is complex and that 
a single screening method is not always sufficient for 
the detection of this kind of isolate [30]. The first MIC 
determination using the AST-card N248 (bioMérieux) 
immediately after arrival of the samples suggested a 
carbapenem-sensitive phenotype according to CLSI-
M100-S24. This was confirmed by a disc diffusion 
assay, as indicated by the CLSI guidelines. However, 
according to the European Food Safety Authority, the 
measured zone diameters for MEM as well as ETP were 
indicative of non-susceptibility to carbapenems [28]. 
When the wild-type isolate and its transformant were 
retested by MIC assay several weeks later, both of them 
exhibited a full resistant phenotype. The identification 
of bacterial isolates harbouring carbapenemase genes 
has frequently been described as challenging. Because 
the presence of a carbapenemase (e.g. KPC, VIM-1) not 
always leads to a high-level carbapenem resistance 
in laboratory testing, the isolates are often wrongly 
assessed as carbapenem-susceptible. Therefore, in 
human medicine, carbapenemase- producing bacte-
ria are often detected only in case of therapy failure 
[31-34]. In 2015, Adams-Sapper et al. described that 
in the case of KPC-producing  K. pneumoniae,  a single 
exposure to a carbapenem was enough to generate 
subpopulations of high-level resistant bacteria [35]. 
Therefore, the real occurrence of carbapenem-resistant 
bacteria in food samples as well as food-producing ani-
mals or the environment can easily be underestimated.
Moreover, it is important to mention the limitations of 
the present study. The screening was based on isolates 
initially selected on MacConkey agar plates contain-
ing 1 µg/mL cefotaxime. Therefore, isolates possess-
ing a carbapenemase of the OXA family (e.g. OXA-48), 
without a coexisting resistance mechanism confer-
ring resistance to oxyimino-cephalosporins such as 
extended spectrum- or AmpC-type beta-lactamases, 
may not have been detected. As the occurrence of 
carbapenemase-producing bacteria in effluent and 
sewage water, hospital sewage as well as river and 
coastal water samples has been described frequently, 
Table 2
Minimum inhibitory concentrations of the Escherichia coli wild-type isolate (E-124–4) derived from retail seafood and its 
transformant (TE-124–4), Germany 2016
Isolate Time of assessment PIP PIP-TAZ CTX CAZ FEP ATM IMI MEM AMK GE TBM CIP TGC FOS COL SXT
E-124–4 11 August 2016 ≥ 128 ≥ 128 4 ≥ 64 ≤ 1 16 ≤ 0.25 ≤ 0.25 ≤ 2 ≤ 1 2 ≤ 0.25 ≤ 0.5 ≤ 16 ≤ 0.5 ≥ 320
E-124–4
21 September 2016
≥ 128 ≥ 128 ≥ 64 ≥ 64 4 ≥ 64 8 ≥ 16 4 2 8 ≤ 0.25 ≤ 0.5 ≤ 16 ≤ 0.5 ≥ 320
TE-124–4 ≥ 128 f ≥ 64 ≥ 64 ≥ 64 ≥ 64 8 8 8 2 8 0.5 ≤ 0.5 ≤ 16 2 ≥ 320
AMK: amikacin; ATM: aztreonam; CAZ: ceftazidime; CIP: ciprofloxacin; COL: colistin; CTX: cefotaxime; f: failed run; FEP: cefepime; 
FOS: fosfomycin; GE: gentamicin; IMI: imipenem; MEM: meropenem; PIP: piperacillin; PIP-TAZ: piperacillin/tazobactam; TBM: tobramycin; 
TGC: tigecycline; SXT: trimethoprim/sulfamethoxazole.
Dark shading: resistant according to CLSI. Light shading: Intermediate according to CLSI.
Minimum inhibitory concentrations [µg/mL] determined by AST-card N248 (VITEK-2 compact system (bioMérieux, Nuertingen, Germany). The 
wild-type isolate (E-124–4) was investigated at two different time points (11 August 2016: after primary detection of the blaVIM-1 gene; 21 
September 2016: after some weeks of cultivation in vitro). TE-124–4: transformant (NEB10-beta containing the IncY plasmid).
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the pollution of seafood was merely a matter of time 
[36-40].
In addition, the detected E. coli sequence type ST10 is 
widespread among clinical as well as animal samples 
(e.g. seagulls) and wastewater [41-45]. In 2014 and 2015, 
a Canadian research group described the occurrence 
of  blaVIM-2- and  blaOXA-48-producing bacteria in seafood 
from China and Korea [6,8]. This study was followed by 
findings such as OXA-23-producing Acinetobacter bau-
manii, isolated from the fish Pagellus acarne harvested 
in the Mediterranean Sea [46], carbapenem-resist-
ant Enterobacter derived from imported retail seafood 
in Canada [47] and VCC-1, a newly described Ambler 
class A carbapenemase from  Vibrio cholerae  isolated 
from imported retail shrimp sold in Canada [48]. These 
findings clearly demonstrate that carbapenemase-pro-
ducing Enterobacteriaceae are present in the oceans 
and may enter the human food chain along this path-
way. Our detection of a carbapenemase-producing  E. 
coli  isolated from a Venus clam, bought at a German 
retail market, supports this theory.
This study showed that the E. coli isolate derived from a 
Venus clam possessed a mixture of different resistance 
genes and parts of resistance plasmids. Interestingly, 
a similar Tn3-like transposon, which harboured a class 
I integron consisting of the  blaVIM-1  gene accompanied 
by  accA4,  aph  (3’)-XV,  aadA1 and  catB2 in its vari-
able region, was recently described in a  K. pneumo-
niae isolated from a river in Switzerland [27]. However, 
the plasmid carrying this integron was different from 
the plasmid in our isolate. These findings underline the 
importance of mobile genetic elements (plasmids or 
transposons) for the spread of carbapenemase-produc-
ing bacteria and demonstrate that this is an important 
risk factor that deserves special attention.
Because the clam was fished in Italy, we compared 
E-124–4 with previously published  blaVIM-1  isolates 
reported from that country: the association 
of  blaVIM-1  and  blaSHV-12  on the same plasmid has 
already been described for Enterobacteriaceae derived 
from an Italian tertiary-care hospital [49], however, 
the detected plasmid replicon type was IncN, while 
the plasmid investigated here belonged to the IncY 
group. In addition, a similar class 1 integron was dis-
covered in  Achromobacter xylosoxydans  isolated 
from a urine sample of an inpatient at the University 
Hospital of Verona, Italy [50]. Similarly to E-124–4, it 
contained  blaVIM-1  accompanied by  accA4,  aph (3’)-
XV and aadA1 in its variable region. However, no catB2 
was detected in that  Achromobacter  isolate. Despite 
the integron similarity, no further consistencies among 
the two plasmids have been detected. While the plas-
mid pAX2220 was 30 kb in size and did not contain an 
additional  blaSHV-12, pE-124–4 was much larger, ca 194 
kb.
Moreover, it has to be taken into account that Venus 
clams are also served as a raw appetiser and that 
seafood is preferred raw in some regions, providing 
ideal conditions for the transmission and spread of the 
carbapenemase-producing bacteria or a transfer of the 
respective plasmids.
This situation emphasises the importance of further 
monitoring programmes as well as the need for the 
seafood samples to be included into the national sur-
veillance programmes. Similarly, comprehensive inter-
vention strategies focussing on the prudent use of 
antibiotics as well as the prevention of an environmen-
tal spread of the resistant bacteria are crucial in human 
as well as veterinary medicine.
*Author’s correction
The GenBank accession number of the blaVIM-1 containing 
transposon region of pE-124-4 was originally published as 
MG18234. This number was corrected to MG182343 on 9 
November 2017.
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